BIOMAT Database Logo BIOMAT Database Logo

Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293). 2000

R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Interlakes Oncology & Hematology, Rochester, New York 14623, USA.

Seventeen patients with enhanced measurable squamous cell carcinoma of the esophagus were treated with topotecan 1.5 mg/m2 daily for 5 days repeated every 21 days. Toxicity was severe, with 1 death from myelotoxicity and 10 patients with life-threatening myelotoxicity. Severe gastrointestinal toxicity consisting of vomiting was also seen in three patients. No response was seen in any of the patients in the study. Topotecan given in this manner has no activity in squamous cell carcinoma of the esophagus.

UI MeSH Term Description Entries
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D019772 Topotecan An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA TOPOISOMERASES, TYPE I. 9-Dimethylaminomethyl-10-hydroxycamptothecin,Hycamtamine,Hycamtin,NSC-609699,Nogitecan Hydrochloride,SK&F-104864-A,SKF-104864-A,Topotecan Hydrochloride,Topotecan Monohydrochloride, (S)-Isomer,9 Dimethylaminomethyl 10 hydroxycamptothecin,Hydrochloride, Nogitecan,Hydrochloride, Topotecan,NSC 609699,NSC609699,SK&F 104864 A,SK&F104864A,SKF 104864 A,SKF104864A

Related Publications

R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.
August 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Primary liver cancer. An Eastern Cooperative Oncology Group Trial.
September 1984, Cancer,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience.
November 1980, Cancer,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study.
November 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study.
January 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93.
June 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Pathogenetic implications of internuclear bridging in myelodysplastic syndrome. An Eastern Cooperative Oncology Group/Southwest Oncology Group Cooperative Study.
December 1989, Cancer,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
May 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Eastern Cooperative Oncology Group (ECOG).
January 1996, Journal of the National Cancer Institute. Monographs,
R F Asbury, and S Lipsitz, and D Graham, and C I Falkson, and L Baez, and A B Benson
Eastern cooperative oncology group studies.
March 1973, Archives of internal medicine,
Copied contents to your clipboard!